SCHEMBL11223576

SCHEMBL11223576

COC(=O)c1cc(Br)c(C(=O)O)c(C)c1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ KMT2A Q03164 4/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ BCL2L1 Q07817 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ RIN1 Q13671 1/20 0.36
▸ SAE1 Q9UBE0 1/20 0.36
▸ UBA2 Q9UBT2 1/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1855578 0.79 SOS1 (0.41) SOS1KMT2AMAPTKDM4EPOLB
SCHEMBL8378635 0.79 SOS1 (0.43) SOS1KMT2AHSD17B10MAPTKDM4E
SCHEMBL11380890 0.75 SOS1 (0.43) SOS1KMT2AHSD17B10MAPTKDM4E
SCHEMBL30057010 0.75 CA1 (0.40) KMT2AHSD17B10MAPTKDM4EABL1
SCHEMBL8338578 0.75 ABL1 (0.40) SOS1KMT2AMAPTKDM4EABL1
SCHEMBL29633948 0.74 LCK (0.60) SOS1LCKFYNKMT2AHSD17B10
SCHEMBL2319843 0.74 LCK (0.60) SOS1LCKFYNKMT2AHSD17B10
SCHEMBL9423556 0.74 CA12 (0.42) LCKFYNHSD17B10MAPTKDM4E
SCHEMBL23051540 0.73 SOS1 (0.50) SOS1LCKFYNHSD17B10MAPT
SCHEMBL197110 0.73 SOS1 (0.50) SOS1LCKFYNKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045796-B2 Process for producing aromatic compound, and palladium complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20180369799-A1 PROCESS FOR PRODUCING AROMATIC COMPOUND, AND PALLADIUM COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-12-27 — — US disclosed
EP-3385270-A1 METHOD FOR PRODUCING AROMATIC COMPOUND, AND PALLADIUM COMPLEX Sumitomo Chemical Company, Ltd (JP) 2018-10-10 — — EP disclosed
US-4309497-A ELECTROGRAPHY, THERMOGRAPHY, DRY PROCESSING EASTMAN KODAK COMPANY (US) 1982-01-05 — — US disclosed
EP-0042261-A2 Electrically activatable recording material and a method of recording an image using the material EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1981-12-23 — — EP disclosed
US-4028308-A Poly(cyclohexanedimethylene dibromoterephthalate) STANDARD OIL COMPANY (INDIANA) (US) 1977-06-07 — — US disclosed
US-4025491-A SELF-EXTINGUISHING STANDARD OIL COMPANY (INDIANA) (US) 1977-05-24 — — US disclosed
US-4024102-A Molding composition suitable for forming improved flame retardant three-dimensional shaped articles CELANESE CORPORATION (US) 1977-05-17 — — US disclosed
US-4001188-A Dimethyl 2,5-dibromoterephthalate esterification STANDARD OIL COMPANY (INDIANA) (US) 1977-01-04 — — US disclosed
US-3966682-A SELF-EXTINGUISHIMG STANDARD OIL COMPANY (US) 1976-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045796-B2 Process for producing aromatic compound, and palladium complex DDT, DRD1, DRD2 SOS1 3881/4885LCK 2418/4885FYN 737/4885
US-20180369799-A1 PROCESS FOR PRODUCING AROMATIC COMPOUND, AND PALLADIUM COMPLEX DDT, DRD1, DRD2 SOS1 3881/4885LCK 2418/4885FYN 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback